Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival.

Guo W, Wang Q, Zhan Y, Chen X, Yu Q, Zhang J, Wang Y, Xu XJ, Zhu L.

Sci Rep. 2016 Jun 24;6:27931. doi: 10.1038/srep27931.

2.

The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches.

Lobbezoo D, Truin W, Voogd A, Roumen R, Vreugdenhil G, Dercksen MW, van den Berkmortel F, Smilde T, van de Wouw A, van Kampen R, van Riel J, Peters N, Peer P, Tjan-Heijnen VC.

Oncotarget. 2016 May 17;7(20):29412-9. doi: 10.18632/oncotarget.8838.

3.

Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development.

Aswad L, Yenamandra SP, Ow GS, Grinchuk O, Ivshina AV, Kuznetsov VA.

Oncotarget. 2015 Nov 3;6(34):36652-74. doi: 10.18632/oncotarget.5543.

4.

Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?

Conlon N, Ross DS, Howard J, Catalano JP, Dickler MN, Tan LK.

Breast J. 2015 Sep-Oct;21(5):514-9. doi: 10.1111/tbj.12445. Epub 2015 Aug 14.

6.

MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.

Bertoli G, Cava C, Castiglioni I.

Theranostics. 2015 Jul 13;5(10):1122-43. doi: 10.7150/thno.11543. eCollection 2015. Review.

7.

Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics.

McCart Reed AE, Kutasovic JR, Lakhani SR, Simpson PT.

Breast Cancer Res. 2015 Jan 30;17:12. doi: 10.1186/s13058-015-0519-x. Review.

8.

Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.

Engstrøm MJ, Opdahl S, Vatten LJ, Haugen OA, Bofin AM.

Histopathology. 2015 Feb;66(3):409-19. doi: 10.1111/his.12572. Epub 2014 Dec 22.

9.

Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.

Cava C, Bertoli G, Ripamonti M, Mauri G, Zoppis I, Della Rosa PA, Gilardi MC, Castiglioni I.

PLoS One. 2014 May 27;9(5):e97681. doi: 10.1371/journal.pone.0097681. eCollection 2014.

10.

Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor.

Narbe U, Bendahl PO, Grabau D, Rydén L, Ingvar C, Fernö M.

Springerplus. 2014 Feb 6;3:70. doi: 10.1186/2193-1801-3-70. eCollection 2014.

11.

Leucoerythroblastosis and thrombocytopenia as clues to metastatic malignancy.

Mahdi EJ, Mahdi AJ.

BMJ Case Rep. 2014 Jan 31;2014. pii: bcr2013202612. doi: 10.1136/bcr-2013-202612.

12.

EZH2 expression in invasive lobular carcinoma of the breast.

Roh S, Park SY, Ko HS, Sohn JS, Cha EJ.

World J Surg Oncol. 2013 Nov 22;11:299. doi: 10.1186/1477-7819-11-299.

13.

Invasive pleomorphic lobular carcinoma of the breast: clinicopathologic characteristics and prognosis compared with invasive ductal carcinoma.

Jung SP, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kim M, Kil WH, Cho EY, Choe JH, Kim JH, Kim JS, Nam SJ, Lee JE.

J Breast Cancer. 2012 Sep;15(3):313-9. doi: 10.4048/jbc.2012.15.3.313. Epub 2012 Sep 28.

14.

Invasive lobular carcinoma predicts micrometastasis in breast cancer.

Gainer SM, Lodhi AK, Bhattacharyya A, Krishnamurthy S, Kuerer HM, Lucci A.

J Surg Res. 2012 Sep;177(1):93-6. doi: 10.1016/j.jss.2012.03.014. Epub 2012 Mar 28.

15.

Case report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation.

Arrangoiz R, Papavasiliou P, Dushkin H, Farma JM.

Int J Surg Case Rep. 2011;2(8):301-5. doi: 10.1016/j.ijscr.2011.06.010. Epub 2011 Oct 12.

16.

Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.

Yi M, Mittendorf EA, Cormier JN, Buchholz TA, Bilimoria K, Sahin AA, Hortobagyi GN, Gonzalez-Angulo AM, Luo S, Buzdar AU, Crow JR, Kuerer HM, Hunt KK.

J Clin Oncol. 2011 Dec 10;29(35):4654-61. doi: 10.1200/JCO.2011.38.3174. Epub 2011 Nov 14.

17.

Platinum resistance in breast and ovarian cancer cell lines.

Eckstein N.

J Exp Clin Cancer Res. 2011 Oct 4;30:91. doi: 10.1186/1756-9966-30-91. Review.

18.

Lobular neoplasia: frequency and association with other breast lesions.

Gomes DS, Balabram D, Porto SS, Gobbi H.

Diagn Pathol. 2011 Aug 9;6:74. doi: 10.1186/1746-1596-6-74.

19.

The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.

Jung SY, Jeong J, Shin SH, Kwon Y, Kim EA, Ko KL, Shin KH, Lee KS, Park IH, Lee S, Kim SW, Kang HS, Ro J.

BMC Cancer. 2010 Dec 3;10:664. doi: 10.1186/1471-2407-10-664.

20.

Breast cancer prognostic classification in the molecular era: the role of histological grade.

Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Richardson AL, Schnitt SJ, Schmitt FC, Tan PH, Tse GM, Badve S, Ellis IO.

Breast Cancer Res. 2010;12(4):207. doi: 10.1186/bcr2607. Epub 2010 Jul 30. Review.

Supplemental Content

Support Center